About Merck & Co., Inc.
https://www.merck.comMerck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health.
CEO
Robert M. Davis
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-06-03 | Forward | 131:125 |
| 1999-02-17 | Forward | 2:1 |
ETFs Holding This Stock
VTS.AX
Weight:0.40%
Shares:78.41M
SCHI
Weight:0.48%
Shares:47.84M
IHVV.AX
Weight:0.45%
Shares:31.80M
Summary
Showing Top 3 of 1,044
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
B of A Securities
Buy
Goldman Sachs
Buy
Guggenheim
Buy
BMO Capital
Outperform
Scotiabank
Sector Outperform
Wells Fargo
Overweight
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:252.14M
Value:$27.99B
BLACKROCK, INC.
Shares:214.88M
Value:$23.85B
BLACKROCK INC.
Shares:207.3M
Value:$23.01B
Summary
Showing Top 3 of 4,447
About Merck & Co., Inc.
https://www.merck.comMerck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $17.28B ▲ | $6.6B ▼ | $5.79B ▲ | 33.49% ▲ | $2.32 ▲ | $8.14B ▲ |
| Q2-2025 | $15.81B ▲ | $6.7B ▲ | $4.43B ▼ | 28.01% ▼ | $1.77 ▼ | $6.42B ▼ |
| Q1-2025 | $15.53B ▼ | $6.17B ▼ | $5.08B ▲ | 32.71% ▲ | $2.02 ▲ | $7.32B ▲ |
| Q4-2024 | $15.62B ▼ | $7.45B ▼ | $3.74B ▲ | 23.96% ▲ | $1.48 ▲ | $5.7B ▲ |
| Q3-2024 | $16.66B | $8.59B | $3.16B | 18.95% | $1.25 | $5.61B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $18.21B ▲ | $129.55B ▲ | $77.64B ▲ | $51.85B ▲ |
| Q2-2025 | $8.62B ▼ | $117.52B ▲ | $68.46B ▲ | $48.99B ▲ |
| Q1-2025 | $9.23B ▼ | $115.12B ▼ | $66.72B ▼ | $48.34B ▲ |
| Q4-2024 | $13.69B ▼ | $117.11B ▼ | $70.73B ▼ | $46.31B ▲ |
| Q3-2024 | $14.59B | $117.53B | $72.97B | $44.5B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.79B ▲ | $7.82B ▲ | $-283M ▲ | $2.64B ▲ | $10.19B ▲ | $6.83B ▲ |
| Q2-2025 | $4.43B ▼ | $3.29B ▲ | $-770M ▲ | $-3.56B ▲ | $-659M ▲ | $2.53B ▲ |
| Q1-2025 | $5.08B ▲ | $2.5B ▼ | $-1.49B ▼ | $-5.75B ▼ | $-4.59B ▼ | $1.17B ▼ |
| Q4-2024 | $3.74B ▲ | $3.45B ▼ | $-1.44B ▲ | $-3.01B ▼ | $-1.37B ▼ | $2.51B ▼ |
| Q3-2024 | $3.16B | $9.29B | $-3.85B | $-2.42B | $3.31B | $8.51B |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Animal Health segment | $1.40Bn ▲ | $1.59Bn ▲ | $1.65Bn ▲ | $1.61Bn ▼ |
 Other Segments | $180.00M ▲ | $300.00M ▲ | $110.00M ▼ | $50.00M ▼ |
 Pharmaceutical segment | $14.04Bn ▲ | $13.64Bn ▼ | $14.05Bn ▲ | $15.61Bn ▲ |
Revenue by Geography
| Region | Q4-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 Asia Pacific | $760.00M ▲ | $790.00M ▲ | $690.00M ▼ | $760.00M ▲ |
 CHINA | $890.00M ▲ | $450.00M ▼ | $700.00M ▲ | $410.00M ▼ |
 EMEA | $3.38Bn ▲ | $3.66Bn ▲ | $3.45Bn ▼ | $3.68Bn ▲ |
 International | $700.00M ▲ | $590.00M ▼ | $700.00M ▲ | $800.00M ▲ |
 JAPAN | $830.00M ▲ | $630.00M ▼ | $670.00M ▲ | $710.00M ▲ |
 Latin America | $870.00M ▲ | $860.00M ▼ | $790.00M ▼ | $910.00M ▲ |
 UNITED STATES | $8.19Bn ▲ | $8.84Bn ▲ | $8.52Bn ▼ | $10.01Bn ▲ |
CEO
Robert M. Davis
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2021-06-03 | Forward | 131:125 |
| 1999-02-17 | Forward | 2:1 |
ETFs Holding This Stock
VTS.AX
Weight:0.40%
Shares:78.41M
SCHI
Weight:0.48%
Shares:47.84M
IHVV.AX
Weight:0.45%
Shares:31.80M
Summary
Showing Top 3 of 1,044
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
B of A Securities
Buy
Goldman Sachs
Buy
Guggenheim
Buy
BMO Capital
Outperform
Scotiabank
Sector Outperform
Wells Fargo
Overweight
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:252.14M
Value:$27.99B
BLACKROCK, INC.
Shares:214.88M
Value:$23.85B
BLACKROCK INC.
Shares:207.3M
Value:$23.01B
Summary
Showing Top 3 of 4,447